Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan

Similar Items

• Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in compensated chronic heart failure patients treated with levosimendan
  od: Figueiredo, EJ de Almeida, i dr.
  Izdano: (2007)
• Correlation of B-type natriuretic peptide and electrocardiographic alteration at presentation and prognosis in patients with non-ST-segment elevation myocardial infarction
  od: Nigri, M, i dr.
  Izdano: (2005)
• The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
  od: Michalopoulou, H, i dr.
  Izdano: (2007)
• Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
  od: McLean, AS, i dr.
  Izdano: (2003)
• In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
  od: Di Somma, Salvatore, i dr.
  Izdano: (2011)